Core Viewpoint - On November 14, 2025, Mindray Medical (300760) closed at 207.7 yuan, experiencing a slight decline of 0.24% with a turnover rate of 0.43% and a trading volume of 51,700 shares, amounting to a transaction value of 1.08 billion yuan [1] Trading Information Summary - On the same day, the net outflow of main funds was 6.4651 million yuan, while speculative and retail investors saw net inflows of 4.8343 million yuan and 1.6308 million yuan, respectively [2][4] - A significant block trade occurred on November 14, with a discount of 14.89%, totaling 5.4625 million yuan [2][4] Company Responses - In response to investor inquiries regarding the negative discount rates in block trades, the company stated that such transactions are based on shareholders' financial arrangements and are not directly related to the company's future development [2] - Regarding R&D investment, the company emphasized its commitment to innovation, maintaining an annual R&D investment of approximately 10% of revenue, which is considered leading in the medical device industry. Cumulative R&D investment since its A-share listing in 2018 has reached 21.556 billion yuan [2] - The company highlighted the lengthy and complex process of medical device innovation, citing that the development of its defibrillator took ten years, including five years to establish certification standards in collaboration with national experts [2]
股市必读:11月14日迈瑞医疗现1笔折价14.89%的大宗交易 合计成交546.25万元